 |
市場調查報告書
商品編碼
1983133
牛疫苗市場：依疫苗類型、疾病適應症、牛類型、給藥途徑、最終用戶、分銷管道和地區分類。Cattle Vaccine Market, By Vaccine Type, By Disease Indication, By Cattle Type, By Route of Administration, By End User, By Distribution Channel, By Geography |
||||||
預計到2026年，牛疫苗市場規模將達到41.3億美元，到2033年將達到61.7億美元。預計從2026年到2033年，其複合年成長率將達到5.9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 41.3億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 5.90% | 2033年市場規模預測： | 61.7億美元 |
全球牛疫苗市場是獸醫醫療產業的關鍵領域，涵蓋了旨在預防全球牛感染疾病的各種免疫生物產品。
隨著畜牧業不斷發展，越來越重視動物健康和福利，牛疫苗已成為維持牛群免疫力和確保農業永續生產力的重要手段。這些疫苗可以保護牛隻免受多種細菌、病毒和寄生蟲疾病的侵害，包括牛呼吸道疾病複合體、牛、布氏桿菌症、炭疽病和梭狀菌感染。
市面上的疫苗種類繁多，包括減毒活病毒疫苗、去活化疫苗、次單位疫苗和重組疫苗，每種疫苗都適用於特定的治療用途和給藥通訊協定。隨著世界人口的成長和對富含蛋白質食物的需求增加，牛正在迅速擴張，因此，強力的疾病預防策略至關重要。
該市場的特點是疫苗研發技術的不斷進步，包括新型佐劑、改進的給藥系統以及具有更廣泛預防效果的聯合疫苗。雖然區域法規結構確保了疫苗的安全性和有效性，但獸醫專業人員和畜牧養殖戶越來越認知到預防性保健措施比被動治療方法更具經濟效益，因此牛疫苗已成為現代畜牧業實踐中不可或缺的一部分。
市場動態
全球牛疫苗市場受多種強勁因素驅動，持續成長。其中最主要的促進因素是全球對牛肉和乳製品的需求不斷成長，這推動了牛數量的增加，並促使人們採用集約化畜牧養殖方式，而這種方式需要全面的疾病預防策略。此外，人們對通用感染疾病及其從牛傳播給人類的可能性認知不斷提高，也促使人們更加關注牲畜疫苗接種計劃，尤其是在畜牧業是重要經濟活動的發展中地區。
疫苗研發的技術進步，包括標記疫苗、耐熱配方和無針給藥系統的引入，正在提高疫苗的功效和便利性，並提高畜牧養殖戶的採用率。
政府對動物健康計畫的舉措和監管支持，以及獸醫保健支出的成長，正在進一步加速市場擴張。然而，也存在諸多限制因素。例如，疫苗研發和監管核准流程的高昂成本可能會限制價格敏感型市場的進入。此外，低溫運輸儲存要求也帶來了物流方面的挑戰，尤其是在基礎設施不足的偏遠農業地區。
此外，一些畜牧養殖戶對疫苗接種的猶豫、對潛在副作用的擔憂以及其他疾病控制方法的存在，都可能阻礙疫苗的市場滲透。儘管如此，新興國家畜牧業的擴張、精準農業技術的日益普及以及人們對有機和無抗生素肉類生產的日益關注，都帶來了巨大的商機。利用重組DNA技術和奈米技術平台開發的新一代疫苗展現出良好的盈利，而疫苗生產商與畜牧養殖戶之間的策略合作正在開闢新的市場管道並加強分銷網路。
本次調查的主要特點。
- 本報告對全球牛疫苗市場進行了詳細分析，給出了預測期（2026-2033 年）的市場規模（以十億美元計）和複合年成長率（CAGR%），其中 2025 年為基準年。
- 該報告揭示了各個細分市場的潛在商機，並說明了該市場中一系列有吸引力的投資提案。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
- 本報告根據以下參數對全球牛疫苗市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
- 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
- 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過分析全球牛疫苗市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 研究目標
- 前提
- 簡稱
第2章 市場範圍
- 報告摘要
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 法規環境
- 產品上市及核准
- PEST分析
- 波特的分析
- 市場機遇
- 法規環境
- 主要進展
- 產業趨勢
第4章 全球牛疫苗市場：依疫苗類型分類，2021-2033年
- 聯合（多價）疫苗
- 去活化（死菌）疫苗
- 減毒活病毒疫苗
- 重組疫苗
- 類毒素疫苗
- DNA/載體疫苗
第5章 全球牛疫苗市場：依疾病適應症分類，2021-2033年
- 牛呼吸道疾病（BRD複合體、IBR、BRSV、PI3）
- 口蹄疫
- 梭狀菌感染（黑腿病、腸毒血症、破傷風）
- 牛病毒性腹瀉（BVD）
- 鉤端螺旋體病
- 乳腺炎
- 布氏桿菌症
- 炭疽病
- 其他疾病（例如約翰氏症和藍舌病）
第6章 全球牛疫苗市場：依牛的種類分類，2021-2033年
- 牛
- 牛
- 種牛
- 牛/牛
第7章 全球牛疫苗市場：依給藥途徑分類，2021-2033年
- 注射疫苗
- 經鼻吸入型疫苗
- 口服疫苗
第8章 全球牛疫苗市場：依最終用戶分類，2021-2033年
- 商業酪農
- 牛養殖場和牧場
- 獸醫醫院和診所
- 政府和機構主導的疫苗接種計劃
第9章 全球牛疫苗市場：依通路分類，2021-2033年
- 直接銷售（從製造商到農場/機構）
- 獸醫醫院和診所
- 動物用藥品藥局和批發商
- 政府採購計劃
第10章 全球牛疫苗市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第11章 競爭格局
- Zoetis
- Boehringer Ingelheim Animal Health
- Merck Animal Health MSD Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- HIPRA
- Virbac
- Vaxxinova
- IDT Biologika
- Biogenesis Bago
- Indian Immunologicals Ltd
- Hester Biosciences Limited
- Jinyu Bio-Technology Co Ltd
- China Animal Husbandry Industry Co Ltd CAHIC
- Bioveta as International
第12章 分析師建議
- 機會
- 分析師意見
- Coherent Opportunity Map
第13章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Cattle Vaccine Market is estimated to be valued at USD 4.13 Bn in 2026 and is expected to reach USD 6.17 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.13 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.90% | 2033 Value Projection: | USD 6.17 Bn |
The global cattle vaccine market represents a critical segment of the veterinary healthcare industry, encompassing a comprehensive range of immunobiological products designed to prevent infectious diseases in cattle populations worldwide.
As livestock farming continues to evolve with increasing emphasis on animal health and welfare, cattle vaccines have become indispensable tools for maintaining herd immunity and ensuring sustainable agricultural productivity. These vaccines protect cattle against various bacterial, viral, and parasitic diseases including bovine respiratory disease complex, foot-and-mouth disease, brucellosis, anthrax, and clostridial infections, among others.
The market encompasses multiple vaccine types including live attenuated, inactivated, subunit, and recombinant vaccines, each serving specific therapeutic purposes and administration protocols. With the global population surge driving increased demand for protein-rich food sources, cattle farming operations are scaling up significantly, necessitating robust disease prevention strategies.
The market is characterized by continuous technological advancements in vaccine development, including novel adjuvants, improved delivery systems, and combination vaccines that offer broader protection spectrums. Regulatory frameworks across different regions ensure vaccine safety and efficacy, while veterinary professionals and livestock producers increasingly recognize the economic benefits of preventive healthcare measures over reactive treatment approaches, positioning cattle vaccines as essential components of modern animal husbandry practices.
Market Dynamics
The global cattle vaccine market is propelled by several compelling drivers that underscore its sustained growth trajectory. The primary driver stems from the escalating global demand for beef and dairy products, necessitating larger cattle populations and intensive farming practices that require comprehensive disease prevention strategies. Rising awareness about zoonotic diseases and their potential transmission from cattle to humans has intensified focus on livestock immunization programs, particularly in developing regions where cattle farming constitutes a significant economic activity.
Technological advancements in vaccine development, including the introduction of marker vaccines, thermostable formulations, and needle-free delivery systems, have enhanced vaccine efficacy and convenience, driving adoption rates among livestock producers.
Government initiatives and regulatory support for animal health programs, coupled with increasing veterinary healthcare expenditure, further accelerate market expansion. However, the market faces notable restraints including the high cost of vaccine development and regulatory approval processes, which can limit accessibility in price-sensitive markets. Cold chain storage requirements pose logistical challenges, particularly in remote agricultural regions with inadequate infrastructure.
Additionally, vaccine hesitancy among some livestock producers, concerns about potential adverse reactions, and the availability of alternative disease management approaches can impede market penetration. Nevertheless, significant opportunities emerge from expanding cattle farming operations in emerging economies, increasing adoption of precision livestock farming technologies, and growing emphasis on organic and antibiotic-free meat production. The development of next-generation vaccines utilizing recombinant DNA technology and nanotechnology platforms presents lucrative prospects, while strategic partnerships between vaccine manufacturers and livestock producers create new market channels and enhance distribution networks.
Key Features of the Study
- This report provides in-depth analysis of the global cattle vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cattle vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim Animal Health, Merck Animal Health MSD Animal Health, Elanco Animal Health, Ceva Sante Animale, HIPRA, Virbac, Vaxxinova, IDT Biologika, Biogenesis Bago, Indian Immunologicals Ltd, Hester Biosciences Limited, Jinyu Bio-Technology Co Ltd, China Animal Husbandry Industry Co Ltd CAHIC, and Bioveta a.s. International
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cattle vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cattle vaccine market
Market Segmentation
- Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
- Combination (Multivalent) Vaccines
- Inactivated (Killed) Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- DNA / Vector-Based Vaccines
- Disease Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
- Foot and Mouth Disease (FMD)
- Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
- Bovine Viral Diarrhea (BVD)
- Leptospirosis
- Mastitis
- Brucellosis
- Anthrax
- Others (Johne's disease, Bluetongue, etc.)
- Cattle Type Insights (Revenue, USD Bn, 2021 - 2033)
- Dairy Cattle
- Beef Cattle
- Breeding Stock
- Calves / Young Stock
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Injectable Vaccines
- Intranasal Vaccines
- Oral Vaccines
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Commercial Dairy Farms
- Beef Farms & Ranches
- Veterinary Clinics & Hospitals
- Government & Institutional Vaccination Programs
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Direct Sales (Manufacturers to Farms/Institutions)
- Veterinary Hospitals & Clinics
- Veterinary Pharmacies & Distributors
- Government Procurement Programs
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis
- Boehringer Ingelheim Animal Health
- Merck Animal Health MSD Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- HIPRA
- Virbac
- Vaxxinova
- IDT Biologika
- Biogenesis Bago
- Indian Immunologicals Ltd
- Hester Biosciences Limited
- Jinyu Bio-Technology Co Ltd
- China Animal Husbandry Industry Co Ltd CAHIC
- Bioveta a.s. International
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cattle Vaccine Market, By Vaccine Type
- Global Cattle Vaccine Market, By Disease Indication
- Global Cattle Vaccine Market, By Cattle Type
- Global Cattle Vaccine Market, By Route of Administration
- Global Cattle Vaccine Market, By End User
- Global Cattle Vaccine Market, By Distribution Channel
- Global Cattle Vaccine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Cattle Vaccine Market, By Vaccine Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Combination (Multivalent) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Inactivated (Killed) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- DNA / Vector-Based Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Cattle Vaccine Market, By Disease Indication, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Foot and Mouth Disease (FMD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bovine Viral Diarrhea (BVD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Leptospirosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mastitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Brucellosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anthrax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (Johne's disease, Bluetongue, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Cattle Vaccine Market, By Cattle Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Dairy Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Beef Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Breeding Stock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Calves / Young Stock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Cattle Vaccine Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Injectable Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Intranasal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Cattle Vaccine Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Commercial Dairy Farms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Beef Farms & Ranches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Clinics & Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government & Institutional Vaccination Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Cattle Vaccine Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Direct Sales (Manufacturers to Farms/Institutions)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Pharmacies & Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government Procurement Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Cattle Vaccine Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck Animal Health MSD Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HIPRA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vaxxinova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDT Biologika
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogenesis Bago
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Indian Immunologicals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hester Biosciences Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jinyu Bio-Technology Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- China Animal Husbandry Industry Co Ltd CAHIC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioveta a.s. International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
獸用抗生素市場：按類別、動物類型、最終用戶和治療領域分類－全球預測，2026-2032年全球畜牧育種市場（按品種、育種目的、育種系統和技術以及分銷管道分類）預測（2026-2032年）獸用角膜護理鏡片市場（依動物種類、產品類型、通路和應用分類）－全球預測，2026-2032年
駱駝痘疫苗市場規模、佔有率和成長分析：按產品類型、傳播途徑、檢測方法、應用、最終用戶和地區分類－2026-2033年產業預測
伴侶動物疫苗市場分析及預測（至2035年）：類型、產品、技術、應用、最終用戶、功能、服務、部署、材料類型、階段獸用抗生素市場分析及預測（至2035年）：類型、產品、應用、劑型、最終用戶、技術、功能與服務獸用疫苗市場分析及預測（至2035年）：類型、產品類型、技術、應用、最終用戶、劑型、組成成分、階段、安裝類型
2026-2034年牛暫緩發熱疫苗全球市場規模、佔有率、趨勢和成長分析報告獸用疫苗全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）畜牧疫苗市場規模、佔有率、成長率及全球市場分析：按類型、應用和地區分類，並預測至2026-2034年